Regulated and controlled B cell response is critical for the effective immune response against the CoVs, as discussed above. However, under certain conditions, B cell response may be detrimental and aggravate the underlying disease condition. A notion has emerged, which suggests that in COVID-19 patients, B cell number though reduced, but these cells display robust activation in some cases that correlate with disease severity.